AFAIK the plan is to continue dosing the next 7 cohorts (including this one) all the way up to 16,000mg. Based on a 3 week turn around from dosing to results, and assuming the tests are consecutive, that should take around 5 months.
I don't know if they will move into Phase II before that or not; the company statement back in June made no mention of anything beyond Phase I.
AFAIK the plan is to continue dosing the next 7 cohorts...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $86.51M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 29.0¢ | $37.22K | 127.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8471 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 17050 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |